Concepedia

Publication | Open Access

The effectiveness and safety of palbociclib and ribociclib in stage IV HR+/HER-2 negative breast cancer: a nationwide real world comparative retrospective cohort study

DOIFull Paper Access

15

Citations

30

References

2023

Year

Nour Hisham Al-Ziftawi, Shereen Elazzazy, M Fasihul Alam, Asrul Akmal Shafie, Anas Hamad, Salha Bbujassoum, Mohamed Izham Mohamed Ibrahim
Frontiers in Oncology

Abstract

Therefore, both treatments have similar efficacy and safety profiles. Further research on a larger-scale population and longer follow-up period is recommeneded.

References

YearCitations

Page 1